CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 25 filers reported holding CLEVELAND BIOLABS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 265 | +1225.0% | 0.00% | – |
| Q3 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 20 | -99.4% | 0.00% | – |
| Q3 2017 | $12,000 | -92.5% | 3,570 | -90.8% | 0.00% | -100.0% |
| Q2 2017 | $159,000 | +189.1% | 38,680 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $55,000 | -11.3% | 38,680 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $62,000 | -18.4% | 38,680 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $76,000 | -7.3% | 38,843 | +6.0% | 0.00% | 0.0% |
| Q2 2016 | $82,000 | -34.9% | 36,643 | -5.7% | 0.00% | -50.0% |
| Q1 2016 | $126,000 | -22.7% | 38,843 | -0.1% | 0.00% | -33.3% |
| Q4 2015 | $163,000 | +3.2% | 38,888 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $158,000 | +192.6% | 38,888 | +106.4% | 0.00% | +200.0% |
| Q2 2015 | $54,000 | -53.4% | 18,843 | -45.1% | 0.00% | -50.0% |
| Q1 2015 | $116,000 | – | 34,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 281,916 | $567,000 | 0.00% |
| VANGUARD GROUP INC | 170,347 | $342,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 20 | $0 | 0.00% |
| UBS Group AG | 2,056 | $4,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 100 | $0 | 0.00% |
| IFP Advisors, Inc | 150 | $0 | 0.00% |
| Advisor Group, Inc. | 25 | $0 | 0.00% |
| US BANCORP \DE\ | 100 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 253 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |